Mankind Pharma Limited (MANKIND.BO)
INR 2846.55
(1.46%)
INR 2846.55
(1.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 44.52 Billion INR | 31.39% |
| 2022 | 33.88 Billion INR | -36.21% |
| 2021 | 53.11 Billion INR | 21.01% |
| 2020 | 43.89 Billion INR | 11.35% |
| 2019 | 39.41 Billion INR | 22.1% |
| 2018 | 32.28 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 13.39 Billion INR | 31.62% |
| 2023 Q1 | 17.58 Billion INR | 120.22% |
| 2023 Q3 | 17.79 Billion INR | -5.52% |
| 2023 FY | 44.52 Billion INR | 31.39% |
| 2023 Q4 | 10.17 Billion INR | -42.81% |
| 2023 Q2 | 18.83 Billion INR | 7.08% |
| 2022 Q4 | 7.98 Billion INR | -42.05% |
| 2022 Q2 | 16.19 Billion INR | 13.68% |
| 2022 Q3 | 13.78 Billion INR | -14.91% |
| 2022 FY | 33.88 Billion INR | -36.21% |
| 2022 Q1 | 14.24 Billion INR | 23.55% |
| 2021 Q4 | 11.53 Billion INR | 0.0% |
| 2021 FY | 53.11 Billion INR | 21.01% |
| 2020 FY | 43.89 Billion INR | 11.35% |
| 2019 FY | 39.41 Billion INR | 22.1% |
| 2018 FY | 32.28 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -111.36% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -2760.265% |
| Sigachi Industries Limited | 2 Billion INR | -2123.509% |
| Bal Pharma Limited | 770.19 Million INR | -5680.476% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -618.733% |
| Medico Remedies Limited | 262.14 Million INR | -16883.39% |
| Lasa Supergenerics Limited | 121.02 Million INR | -36685.044% |
| Venus Remedies Limited | 2.18 Billion INR | -1939.826% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 7490.52% |
| Alpa Laboratories Limited | 188.89 Million INR | -23469.146% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -1397.982% |
| Shilpa Medicare Limited | 3.54 Billion INR | -1155.221% |
| Aarti Drugs Limited | 8.31 Billion INR | -435.352% |
| Lupin Limited | 123.71 Billion INR | 64.014% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 71.218% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 64.443% |
| Windlas Biotech Limited | 1.33 Billion INR | -3225.436% |
| Suven Life Sciences Limited | -200.79 Million INR | 22272.113% |
| Eris Lifesciences Limited | 10.42 Billion INR | -326.986% |
| Valiant Laboratories Limited | -60.66 Million INR | 73489.387% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -96.128% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -5069.64% |
| Ipca Laboratories Limited | 29.8 Billion INR | -49.35% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1104.755% |
| Achyut Healthcare Limited | 4.86 Million INR | -915780.23% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 82.776% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -2924.919% |
| RPG Life Sciences Limited | 2.48 Billion INR | -1693.03% |
| Laurus Labs Limited | 24.62 Billion INR | -80.832% |
| Piramal Pharma Limited | 24.47 Billion INR | -81.934% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -4624.213% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 4.783% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -66.243% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 35.794% |
| Unichem Laboratories Limited | 4.86 Billion INR | -815.14% |
| Sequent Scientific Limited | 2.97 Billion INR | -1394.628% |
| Novartis India Limited | 1.32 Billion INR | -3255.259% |
| Wanbury Limited | 1.73 Billion INR | -2472.508% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -979.747% |
| Wockhardt Limited | 16.24 Billion INR | -174.144% |
| Themis Medicare Limited | 1.5 Billion INR | -2860.358% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -6722.191% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -126.65% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -258.087% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 72.788% |
| Divi's Laboratories Limited | 32.44 Billion INR | -37.241% |
| NATCO Pharma Limited | 25.73 Billion INR | -72.991% |
| Gufic Biosciences Limited | 4.16 Billion INR | -968.236% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -871.903% |
| Ind-Swift Limited | 2.17 Billion INR | -1949.266% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -670.072% |
| FDC Limited | 8.33 Billion INR | -434.161% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -23000.519% |
| Granules India Limited | 16.79 Billion INR | -165.017% |
| Medicamen Biotech Limited | 495.49 Million INR | -8885.144% |
| Alkem Laboratories Limited | 52.29 Billion INR | 14.869% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -615.46% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -305262.511% |
| Brooks Laboratories Limited | 65.62 Million INR | -67746.599% |
| Megasoft Limited | 342.07 Million INR | -12915.116% |
| ZIM Laboratories Limited | 1.26 Billion INR | -3414.2% |
| Strides Pharma Science Limited | 14.38 Billion INR | -209.429% |
| Neuland Laboratories Limited | 8.24 Billion INR | -439.789% |
| Morepen Laboratories Limited | 6.16 Billion INR | -622.592% |
| Hikal Limited | 3.14 Billion INR | -1316.475% |
| Indoco Remedies Limited | 6.04 Billion INR | -636.94% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -663.475% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -7075.276% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -6227.547% |
| Hester Biosciences Limited | 1.27 Billion INR | -3395.539% |